In this issue:
Antithrombotic therapy for patients who are underweight or obese
Trisomy 21 and CHD
ESC 2024 Guidelines for elevated BP and hypertension management
Evaluation and management of kidney dysfunction in advanced HF
Meeting your professional obligations when using AI in healthcare
Error in Brand Price Premiums for Sevikar 20/5 and Sevikar 40/10
Release of Stage 3 for 60-day prescriptions
November 2024 PBAC meeting agenda
Pathology forms have been updated
Upcoming changes to MBS chronic disease management arrangements
Public consultation: Acute coronary syndrome guidelines
A novel heart attack test can lead to shorter ED stays
SCOFF trial confirms fasting is unnecessary before catheter lab procedures
Finerenone improves outcomes in common HF
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)